Acquisition by Mark Alles of 33809 shares of Celgene subject to Rule 16b 3

Celgene financial leverage refers to using borrowed capital as a funding source to finance Celgene ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Celgene financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Celgene's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Celgene's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Celgene's total debt and its cash.

To perform a cash flow analysis of Celgene, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Celgene is receiving and how much cash it distributes out in a given period. The Celgene cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.